AI-generated from publicly available materials.Molecular Devices and STEMCELL Technologies have collaborated to create an automated workflow designed for culturing human intestinal organoids, utilizing STEMCELL's IntestiCult Plus medium on the CellXpress.ai system.
This new workflow, which is available as a downloadable protocol, aims to streamline the organoid culture process by minimizing hands-on time and experimental variability. The goal is to enable researchers to generate more consistent and scalable human-relevant models, thereby accelerating the discovery process in life sciences. This initiative represents the first phase of a broader partnership focused on automating various organoid culture kits offered by STEMCELL.
Mary Duseau, president of Molecular Devices, highlighted the importance of this collaboration in making advanced cellular models more accessible. By merging STEMCELL's expertise in organoid biology with Molecular Devices' automation technologies, the companies intend to lower barriers for researchers and enhance laboratory workflows globally. The automated system not only facilitates culture and monitoring but also allows for flexibility in adapting protocols to meet specific research needs.
As the partnership progresses, the companies plan to explore additional organoid models and workflows for automation, ultimately creating a comprehensive suite of validated applications for drug discovery, disease modeling, and translational research. This collaboration could significantly impact the field by making organoid research more efficient and reproducible, thus fostering innovation in therapeutic development.